Search research articles
Contact Us
Filters
Showing results (81-90 of 109) with videos related to
Page
of 11
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian sex cord stromal tumors
Isabelle Ray-Coquard, Jubilee Brown, Philipp Harter, et al.
Gynecologic Oncology
|
May 7, 2011
Correlation between CA-125 serum level and response by RECIST in a phase III recurrent ovarian cancer study
Thomas J Herzog, Jan B Vermorken, Eric Pujade-Lauraine, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for small cell carcinoma of the cervix
Toyomi Satoh, Yuji Takei, Isabelle Treilleux, et al.
Cancers
|
August 14, 2020
Modeling the Diversity of Epithelial Ovarian Cancer through Ten Novel Well Characterized Cell Lines Covering Multiple Subtypes of the Disease
Skye Alexandre Sauriol, Kayla Simeone, Lise Portelance, et al.
Oncogene
|
August 16, 2006
Transfer of chromosome 3 fragments suppresses tumorigenicity of an ovarian cancer cell line monoallelic for chromosome 3p
N A L Cody, V Ouellet, E N Manderson, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
March 10, 2012
Allelic transcripts dosage effect in morphologically normal ovarian cells from heterozygous carriers of a BRCA1/2 French Canadian founder mutation
Diala Abd-Rabbo, Christine Abaji, Guillaume B Cardin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors)
Philipp Harter, David Gershenson, Catherine Lhomme, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for uterine serous carcinoma
Satoru Sagae, Nobuyuki Susumu, Akila N Viswanathan, et al.
Gynecologic Oncology
|
January 29, 2023
Results of TRIO-15, a multicenter, open-label, phase II study of the efficacy and safety of ganitumab in patients with recurrent platinum-sensitive ovarian cancer
T M Davidson, C L Lebreton, A E Wahner Hendricksen, et al.
Plos One
|
October 3, 2012
The genomic landscape of TP53 and p53 annotated high grade ovarian serous carcinomas from a defined founder population associated with patient outcome
Paulina M Wojnarowicz, Kathleen Klein Oros, Michael C J Quinn, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 109) with videos related to
Sort By:
Page
of 11
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian sex cord stromal tumors
Isabelle Ray-Coquard, Jubilee Brown, Philipp Harter, et al.
Gynecologic Oncology
|
May 7, 2011
Correlation between CA-125 serum level and response by RECIST in a phase III recurrent ovarian cancer study
Thomas J Herzog, Jan B Vermorken, Eric Pujade-Lauraine, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for small cell carcinoma of the cervix
Toyomi Satoh, Yuji Takei, Isabelle Treilleux, et al.
Cancers
|
August 14, 2020
Modeling the Diversity of Epithelial Ovarian Cancer through Ten Novel Well Characterized Cell Lines Covering Multiple Subtypes of the Disease
Skye Alexandre Sauriol, Kayla Simeone, Lise Portelance, et al.
Oncogene
|
August 16, 2006
Transfer of chromosome 3 fragments suppresses tumorigenicity of an ovarian cancer cell line monoallelic for chromosome 3p
N A L Cody, V Ouellet, E N Manderson, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
March 10, 2012
Allelic transcripts dosage effect in morphologically normal ovarian cells from heterozygous carriers of a BRCA1/2 French Canadian founder mutation
Diala Abd-Rabbo, Christine Abaji, Guillaume B Cardin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors)
Philipp Harter, David Gershenson, Catherine Lhomme, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for uterine serous carcinoma
Satoru Sagae, Nobuyuki Susumu, Akila N Viswanathan, et al.
Gynecologic Oncology
|
January 29, 2023
Results of TRIO-15, a multicenter, open-label, phase II study of the efficacy and safety of ganitumab in patients with recurrent platinum-sensitive ovarian cancer
T M Davidson, C L Lebreton, A E Wahner Hendricksen, et al.
Plos One
|
October 3, 2012
The genomic landscape of TP53 and p53 annotated high grade ovarian serous carcinomas from a defined founder population associated with patient outcome
Paulina M Wojnarowicz, Kathleen Klein Oros, Michael C J Quinn, et al.
Page
of 11